<!DOCTYPE html>
<html lang="en">

<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Lesson 4.1: The Inflammaging Phenomenon: Menopause and Systemic Inflammation</title>
    <style>
        /* Base & Reset */
        * {
            box-sizing: border-box;
        }

        body {
            font-family: Georgia, 'Times New Roman', serif;
            line-height: 1.8;
            color: #2d2d2d;
            background: #f8f6f3;
            margin: 0;
            padding: 0;
        }

        /* Main Container */
        .lesson-container {
            max-width: 860px;
            margin: 0 auto;
            padding: 40px 30px;
            background: #ffffff;
            min-height: 100vh;
            box-shadow: 0 0 60px rgba(0, 0, 0, 0.08);
        }

        /* Brand Header */
        .brand-header {
            text-align: center;
            padding-bottom: 30px;
            margin-bottom: 35px;
            border-bottom: 1px solid #eee;
        }

        .brand-logo {
            max-width: 220px;
            height: auto;
            margin-bottom: 5px;
        }

        /* Module Header - FIRE/ORANGE theme for Inflammation */
        .module-header {
            background: linear-gradient(135deg, #c2410c 0%, #ea580c 100%);
            padding: 35px 35px 30px;
            border-radius: 16px;
            margin-bottom: 30px;
            position: relative;
            overflow: hidden;
        }

        .module-header::before {
            content: '';
            position: absolute;
            top: 0;
            right: 0;
            width: 300px;
            height: 300px;
            background: radial-gradient(circle, rgba(255, 255, 255, 0.1) 0%, transparent 70%);
            transform: translate(100px, -100px);
        }

        .module-header::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 100%;
            height: 4px;
            background: linear-gradient(90deg, #B8860B, #D4A84B, #B8860B);
        }

        .module-label {
            margin: 0;
            font-size: 11px;
            color: rgba(255, 255, 255, 0.75);
            text-transform: uppercase;
            letter-spacing: 2.5px;
            font-weight: 500;
        }

        .lesson-title {
            margin: 10px 0 0 0;
            font-size: 28px;
            color: #ffffff;
            font-weight: 700;
            line-height: 1.3;
            position: relative;
        }

        .lesson-meta {
            display: flex;
            gap: 12px;
            margin-top: 20px;
            padding-top: 18px;
            border-top: 1px solid rgba(255, 255, 255, 0.15);
            flex-wrap: wrap;
        }

        .meta-item {
            display: flex;
            align-items: center;
            gap: 6px;
            font-size: 12px;
            color: rgba(255, 255, 255, 0.85);
            background: rgba(255, 255, 255, 0.1);
            padding: 5px 12px;
            border-radius: 4px;
        }

        /* Table of Contents */
        .toc-box {
            background: linear-gradient(135deg, #fafafa 0%, #f5f5f5 100%);
            border-radius: 14px;
            padding: 24px 28px;
            margin-bottom: 35px;
            border: 1px solid #e8e8e8;
        }

        .toc-box .box-label {
            font-weight: 600;
            color: #c2410c;
            margin: 0 0 18px 0;
            font-size: 12px;
            text-transform: uppercase;
            letter-spacing: 2px;
            padding-bottom: 12px;
            border-bottom: 1px solid #e0e0e0;
        }

        .toc-list {
            list-style: none;
            margin: 0;
            padding: 0;
            display: grid;
            grid-template-columns: repeat(2, 1fr);
            gap: 8px 24px;
        }

        .toc-list li {
            margin: 0;
        }

        .toc-list a {
            display: flex;
            align-items: center;
            padding: 8px 12px;
            color: #555;
            text-decoration: none;
            font-size: 14px;
            border-radius: 6px;
            transition: all 0.2s ease;
        }

        .toc-list a:hover {
            background: white;
            color: #c2410c;
            box-shadow: 0 2px 8px rgba(0, 0, 0, 0.06);
        }

        .toc-list .section-num {
            display: inline-flex;
            align-items: center;
            justify-content: center;
            width: 26px;
            height: 26px;
            background: #c2410c;
            color: white;
            font-weight: 600;
            font-size: 11px;
            border-radius: 6px;
            margin-right: 12px;
            flex-shrink: 0;
        }

        /* Learning Objectives */
        .objectives-box {
            background: #fff7ed;
            border: 2px solid #ea580c;
            border-radius: 14px;
            padding: 30px 35px;
            margin-bottom: 40px;
        }

        .objectives-box .box-label {
            font-weight: 600;
            color: #c2410c;
            margin: 0 0 18px 0;
            font-size: 13px;
            text-transform: uppercase;
            letter-spacing: 2px;
            display: flex;
            align-items: center;
            gap: 10px;
        }

        .objectives-box .box-label::before {
            content: 'ðŸŽ¯';
            font-size: 18px;
        }

        .objectives-box ul {
            margin: 0;
            padding-left: 22px;
        }

        .objectives-box li {
            margin-bottom: 14px;
            font-size: 16px;
            line-height: 1.7;
        }

        /* Key Terms Box */
        .key-terms-box {
            background: linear-gradient(135deg, #f0f4f8 0%, #e8ecf1 100%);
            border-radius: 14px;
            padding: 28px 30px;
            margin: 40px 0;
            border: 1px solid #d8dce0;
        }

        .key-terms-box .box-label {
            font-weight: 600;
            color: #c2410c;
            margin: 0 0 18px 0;
            font-size: 13px;
            text-transform: uppercase;
            letter-spacing: 2px;
        }

        .terms-grid {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(280px, 1fr));
            gap: 16px;
        }

        .term-item {
            background: white;
            padding: 16px 18px;
            border-radius: 10px;
            border-left: 4px solid #ea580c;
        }

        .term-item .term {
            font-weight: 700;
            color: #c2410c;
            font-size: 15px;
            margin: 0 0 6px 0;
        }

        .term-item .definition {
            font-size: 14px;
            color: #555;
            margin: 0;
            line-height: 1.6;
        }

        /* Section Headings */
        h2 {
            font-size: 24px;
            color: #c2410c;
            margin: 50px 0 20px 0;
            font-weight: 600;
            position: relative;
            padding-bottom: 12px;
        }

        h2::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 60px;
            height: 3px;
            background: #B8860B;
        }

        /* Paragraphs */
        p {
            font-size: 17px;
            margin-bottom: 20px;
            color: #333;
        }

        .highlight {
            background: linear-gradient(180deg, transparent 60%, #ffedd5 60%);
            padding: 0 4px;
            font-weight: 500;
        }

        /* Case Study Box */
        .case-study {
            background: linear-gradient(135deg, #f8f9fb 0%, #f0f2f5 100%);
            border-radius: 16px;
            padding: 0;
            margin: 40px 0;
            overflow: hidden;
            box-shadow: 0 4px 20px rgba(0, 0, 0, 0.06);
        }

        .case-study-header {
            background: linear-gradient(135deg, #c2410c 0%, #ea580c 100%);
            padding: 20px 30px;
            display: flex;
            align-items: center;
            gap: 15px;
        }

        .case-study-icon {
            width: 45px;
            height: 45px;
            background: rgba(255, 255, 255, 0.15);
            border-radius: 10px;
            display: flex;
            align-items: center;
            justify-content: center;
            font-size: 22px;
        }

        .case-study-header .box-label {
            font-weight: 600;
            color: #ffffff;
            margin: 0;
            font-size: 16px;
        }

        .case-study-content {
            padding: 28px 30px;
        }

        .patient-profile {
            display: flex;
            align-items: center;
            gap: 18px;
            padding: 18px 22px;
            background: white;
            border-radius: 12px;
            margin-bottom: 20px;
            border: 1px solid #e5e5e5;
        }

        .patient-avatar {
            width: 55px;
            height: 55px;
            background: linear-gradient(135deg, #ea580c, #c2410c);
            border-radius: 50%;
            display: flex;
            align-items: center;
            justify-content: center;
            font-size: 24px;
            color: white;
        }

        /* Statistics Box */
        .stats-box {
            background: linear-gradient(135deg, #c2410c 0%, #ea580c 100%);
            padding: 40px;
            border-radius: 16px;
            margin: 35px 0;
            position: relative;
            overflow: hidden;
        }

        .stats-grid {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(140px, 1fr));
            gap: 25px;
            position: relative;
            z-index: 1;
        }

        .stat-item {
            text-align: center;
        }

        .stat-number {
            font-size: 42px;
            font-weight: 700;
            color: white;
            line-height: 1;
            margin-bottom: 8px;
        }

        .stat-label {
            font-size: 13px;
            color: rgba(255, 255, 255, 0.85);
            text-transform: uppercase;
            letter-spacing: 1px;
        }

        /* Data Table */
        .data-table-container {
            margin: 30px 0;
            overflow-x: auto;
            border-radius: 12px;
            border: 1px solid #e5e5e5;
        }

        table {
            width: 100%;
            border-collapse: collapse;
            font-size: 15px;
        }

        th {
            background: #fff7ed;
            color: #c2410c;
            padding: 15px;
            text-align: left;
            border-bottom: 2px solid #ea580c;
        }

        td {
            padding: 15px;
            border-bottom: 1px solid #eee;
        }

        tr:last-child td {
            border-bottom: none;
        }

        /* Alert Boxes */
        .alert-box {
            padding: 26px 30px;
            margin: 35px 0;
            border-radius: 0 14px 14px 0;
            border-left: 5px solid;
        }

        .alert-box.info {
            background: #eff6ff;
            border-left-color: #3b82f6;
        }

        .alert-box.warning {
            background: #fff7ed;
            border-left-color: #f97316;
        }

        /* Check Understanding */
        .check-understanding {
            background: linear-gradient(135deg, #fdfbf7 0%, #f9f5ed 100%);
            border: 2px solid #B8860B;
            border-radius: 16px;
            padding: 32px;
            margin: 45px 0;
        }

        .reveal-btn {
            background: #c2410c;
            color: white;
            border: none;
            padding: 10px 20px;
            border-radius: 8px;
            cursor: pointer;
            margin-top: 10px;
        }

        .answer-text {
            display: none;
            margin-top: 15px;
            padding: 15px;
            background: #fff;
            border-radius: 8px;
            border-left: 4px solid #ea580c;
        }

        /* Takeaways */
        .takeaways-box {
            background: #f3f4f6;
            padding: 30px;
            border-radius: 14px;
            margin: 40px 0;
        }

        .takeaways-box .box-label {
            color: #c2410c;
            font-weight: 700;
            text-transform: uppercase;
            margin-bottom: 15px;
            display: block;
        }

        /* References */
        .references-box {
            margin-top: 50px;
            padding-top: 30px;
            border-top: 1px solid #eee;
            font-size: 14px;
            color: #666;
        }

        .references-box h4 {
            color: #333;
            margin-bottom: 15px;
        }

        .references-box ul {
            list-style: none;
            padding: 0;
        }

        .references-box li {
            margin-bottom: 10px;
            line-height: 1.5;
        }

        /* Footer */
        .lesson-footer {
            text-align: center;
            padding: 40px 0;
            border-top: 1px solid #eee;
            margin-top: 40px;
        }

        @media (max-width: 768px) {
            .toc-list { grid-template-columns: 1fr; }
            .stats-grid { grid-template-columns: 1fr 1fr; }
        }
    </style>
</head>

<body>
    <div class="lesson-container">
        <div class="brand-header">
            <img src="/logoimg/LOGO_ACCREDI.png" alt="AccrediPro Academy" class="brand-logo">
        </div>

        <header class="module-header">
            <p class="module-label">Module 4: I: Inflammation Control</p>
            <h1 class="lesson-title">Lesson 4.1: The Inflammaging Phenomenon: Menopause and Systemic Inflammation</h1>
            <div class="lesson-meta">
                <span class="meta-item">35 min read</span>
                <span class="meta-item">Lesson 1 of 4</span>
            </div>
        </header>

        <div class="toc-box">
            <p class="box-label">In This Lesson</p>
            <ul class="toc-list">
                <li><a href="#defining-inflammaging"><span class="section-num">1</span>Defining Inflammaging</a></li>
                <li><a href="#cytokine-shift"><span class="section-num">2</span>The Estrogen Shield & Cytokine Shift</a></li>
                <li><a href="#hidden-driver"><span class="section-num">3</span>The Hidden Driver of Symptoms</a></li>
                <li><a href="#long-term-risks"><span class="section-num">4</span>Long-term Health Implications</a></li>
                <li><a href="#thrive-approach"><span class="section-num">5</span>The THRIVE Approach to Cooling</a></li>
                <li><a href="#practitioner-role"><span class="section-num">6</span>Your Role as a Coach</a></li>
            </ul>
        </div>

        <div class="objectives-box">
            <p class="box-label">Learning Objectives</p>
            <ul>
                <li>Define the concept of "Inflammaging" and its specific acceleration during the menopausal transition.</li>
                <li>Explain the biochemical shift from anti-inflammatory to pro-inflammatory cytokine profiles (IL-6, TNF-alpha).</li>
                <li>Connect systemic inflammation to the severity of vasomotor symptoms and musculoskeletal pain.</li>
                <li>Analyze the link between chronic low-grade inflammation and the increased risk of cardiovascular and neurodegenerative diseases post-menopause.</li>
                <li>Introduce the "I" (Inflammation Control) component of the T.H.R.I.V.E. Methodologyâ„¢.</li>
            </ul>
        </div>

        <h2 id="defining-inflammaging">1. Defining 'Inflammaging' in the Menopausal Context</h2>
        <p>For decades, menopause was viewed primarily through the lens of reproductive senescenceâ€”a simple "turning off" of the ovaries. However, modern geroscience has revealed a much more complex biological shift. We now understand that the menopausal transition is a primary accelerator of <span class="highlight">Inflammaging</span>.</p>
        
        <p>Inflammaging is defined as a chronic, low-grade, sterile (non-infectious) inflammation that develops during aging. In women, this process is not linear; it undergoes a sharp "inflection point" during perimenopause. As estrogen levels fluctuate and eventually decline, the bodyâ€™s innate immune system shifts into a state of constant, low-level activation.</p>

        <div class="alert-box info">
            <p class="alert-label">The Biological Inflection Point</p>
            <p>Unlike chronological aging, which happens day by day, "Menopausal Inflammaging" is characterized by a rapid surge in inflammatory markers that often outpaces a woman's actual age. This explains why many women feel they "aged ten years in one" during the transition.</p>
        </div>

        <h2 id="cytokine-shift">2. The Estrogen Shield & The Shift in Cytokine Profiles</h2>
        <p>To understand inflammation, we must understand <span class="highlight">cytokines</span>â€”the signaling proteins that modulate the immune response. During the reproductive years, estrogen (specifically estradiol) acts as a potent anti-inflammatory shield. It suppresses the production of pro-inflammatory cytokines by inhibiting the NF-ÎºB pathway, a "master switch" for inflammation.</p>

        <p>As estrogen declines, this inhibition is lost. The result is a dramatic shift in the "Cytokine Symphony." The body begins to overproduce "alarm" proteins that keep the system in a state of high alert.</p>

        <div class="stats-box">
            <div class="stats-grid">
                <div class="stat-item">
                    <div class="stat-number">48%</div>
                    <div class="stat-label">Increase in IL-6</div>
                </div>
                <div class="stat-item">
                    <div class="stat-number">3.2x</div>
                    <div class="stat-label">TNF-Î± Elevation</div>
                </div>
                <div class="stat-item">
                    <div class="stat-number">1.5mg/L</div>
                    <div class="stat-label">Avg. CRP Rise</div>
                </div>
            </div>
        </div>

        <div class="data-table-container">
            <table>
                <thead>
                    <tr>
                        <th>Cytokine/Marker</th>
                        <th>Pre-Menopausal Role</th>
                        <th>Menopausal Shift</th>
                        <th>Systemic Impact</th>
                    </tr>
                </thead>
                <tbody>
                    <tr>
                        <td><strong>Interleukin-6 (IL-6)</strong></td>
                        <td>Regulated/Low</td>
                        <td>Significant Increase</td>
                        <td>Muscle breakdown, fatigue, and insulin resistance.</td>
                    </tr>
                    <tr>
                        <td><strong>TNF-Alpha</strong></td>
                        <td>Immune surveillance</td>
                        <td>Chronic Elevation</td>
                        <td>Bone loss (osteoporosis) and vascular damage.</td>
                    </tr>
                    <tr>
                        <td><strong>C-Reactive Protein (CRP)</strong></td>
                        <td>Acute response only</td>
                        <td>Baseline Elevation</td>
                        <td>A key marker for future cardiovascular events.</td>
                    </tr>
                    <tr>
                        <td><strong>Interleukin-10</strong></td>
                        <td>High (Anti-inflammatory)</td>
                        <td>Decrease</td>
                        <td>Loss of the "brakes" on the inflammatory system.</td>
                    </tr>
                </tbody>
            </table>
        </div>

        <h2 id="hidden-driver">3. The Hidden Driver: VMS and Joint Pain</h2>
        <p>As a Menopause Support Coach, you will often hear clients complain of "aching all over" or hot flashes that feel like an internal furnace. We now know these aren't just "hormone symptoms"â€”they are <span class="highlight">inflammatory symptoms</span>.</p>

        <p><strong>Vasomotor Symptoms (VMS):</strong> Recent studies, including data from the SWAN (Study of Women's Health Across the Nation), show that women with the highest levels of IL-6 and CRP experience the most frequent and severe hot flashes. VMS is now considered a marker of vascular inflammation and endothelial dysfunction.</p>

        <p><strong>Musculoskeletal Pain:</strong> Estrogen receptors are located throughout the joint tissues, including the synovium and cartilage. When estrogen drops, the increase in TNF-alpha and IL-1Î² leads to the degradation of collagen and the sensitization of pain receptors. This is the physiological basis for "Menopausal Arthritis."</p>

        <div class="case-study">
            <div class="case-study-header">
                <div class="case-study-icon">ðŸ‘¤</div>
                <div>
                    <p class="box-label">Case Study: The "Aching" Executive</p>
                    <p style="color: white; font-size: 13px; margin: 0;">Client: Sarah, Age 51</p>
                </div>
            </div>
            <div class="case-study-content">
                <div class="patient-profile">
                    <div class="patient-avatar">S</div>
                    <div class="patient-info">
                        <h4>Sarah (Perimenopausal)</h4>
                        <p>Symptoms: Severe morning joint stiffness, Brain fog, 15+ Hot flashes/day.</p>
                    </div>
                </div>
                <p><strong>Initial Presentation:</strong> Sarah believed she was developing rheumatoid arthritis. Her blood work showed "normal" ranges for autoimmune markers, but her hs-CRP was 3.8 mg/L (elevated risk). She was using high doses of ibuprofen with little relief.</p>
                <p><strong>Intervention:</strong> Using the <strong>THRIVE Methodologyâ„¢</strong>, we focused on the "I" (Inflammation Control). We transitioned her to a high-phytonutrient, Mediterranean-style protocol, added therapeutic Omega-3s (3g/day), and implemented restorative sleep hygiene to lower nocturnal cortisol.</p>
                <p><strong>Outcome:</strong> Within 6 weeks, Sarah's hs-CRP dropped to 1.1 mg/L. Her joint pain reduced by 70%, and her hot flashes became "manageable" at 2-3 per day, proving the inflammatory nature of her symptoms.</p>
            </div>
        </div>

        <h2 id="long-term-risks">4. Long-term Health Implications: Beyond the Symptoms</h2>
        <p>The danger of untreated inflammaging is that it is often "silent." While a woman may focus on the inconvenience of hot flashes, the underlying systemic inflammation is quietly laying the groundwork for chronic diseases of aging.</p>

        <ul>
            <li><strong>Cardiovascular Disease (CVD):</strong> Inflammation causes the oxidation of LDL cholesterol and the formation of arterial plaques. Post-menopause, a woman's risk of heart disease catches up to and often exceeds that of men, largely driven by this inflammatory shift.</li>
            <li><strong>Neuroinflammation:</strong> The brain is highly sensitive to systemic cytokines. Elevation in TNF-alpha can cross the blood-brain barrier, activating the brain's immune cells (microglia). This contributes to the "brain fog" Sarah experienced and increases the long-term risk of Alzheimer's and dementia.</li>
            <li><strong>Metabolic Dysfunction:</strong> Chronic inflammation interferes with insulin signaling. This creates a vicious cycle: inflammation causes insulin resistance, which leads to weight gain (the 'Meno-belly'), and visceral fat then produces *more* inflammatory cytokines.</li>
        </ul>

        <h2 id="thrive-approach">5. The THRIVE Approach to Cooling the Internal Environment</h2>
        <p>In the <strong>T.H.R.I.V.E. Menopause Methodâ„¢</strong>, the "I" stands for <span class="highlight">Inflammation Control</span>. We do not simply wait for inflammation to occur; we proactively "cool" the environment using five primary levers:</p>

        <div class="principle-card">
            <p class="principle-title">1. Nutritional Anti-Inflammatories</p>
            <p class="principle-text">Moving beyond "dieting" to focus on high-ORAC (Oxygen Radical Absorbance Capacity) foods that neutralize oxidative stress. This will be the focus of Lesson 4.4.</p>
        </div>

        <div class="principle-card" style="border-left-color: #B8860B;">
            <p class="principle-title">2. Glycemic Variability Management</p>
            <p class="principle-text">Blood sugar spikes are pro-inflammatory. Stabilizing glucose is a prerequisite for systemic cooling.</p>
        </div>

        <div class="principle-card">
            <p class="principle-title">3. Gut Barrier Integrity</p>
            <p class="principle-text">Addressing "leaky gut" to prevent lipopolysaccharides (LPS) from entering the bloodstream and triggering an immune response.</p>
        </div>

        <h2 id="practitioner-role">6. Your Role as a Menopause Support Coach</h2>
        <p>As a coach, your objective is to help the client connect the dots between her lifestyle and her "internal heat." Many women accept joint pain and fatigue as an inevitable part of aging. Your role is to educate them that <span class="highlight">inflammation is a variable they can influence.</span></p>

        <p>By identifying inflammatory triggersâ€”whether they be ultra-processed foods, chronic stress, or poor sleepâ€”you empower the client to regain control over her biology. In the upcoming lessons, we will look at how to assess these inflammatory loads and the specific kitchen protocols to dampen the fire.</p>

        <div class="check-understanding">
            <p class="box-label">Check Your Understanding</p>
            <p class="box-subtitle">Test your knowledge of the inflammaging phenomenon.</p>

            <div class="question-item">
                <div class="question-number">1</div>
                <p class="question-text">Which "master switch" pathway does estrogen normally inhibit to prevent systemic inflammation?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Reveal Answer</button>
                <div class="answer-text">The <strong>NF-ÎºB (Nuclear Factor kappa-light-chain-enhancer of activated B cells)</strong> pathway. When estrogen declines, this inhibition is lost, leading to increased production of pro-inflammatory cytokines.</div>
            </div>

            <div class="question-item">
                <div class="question-number">2</div>
                <p class="question-text">True or False: Hot flashes are purely a result of the hypothalamus being "confused" by low estrogen.</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Reveal Answer</button>
                <div class="answer-text"><strong>False.</strong> While the hypothalamus is involved, severe hot flashes (VMS) are now recognized as markers of <strong>systemic vascular inflammation</strong> and are correlated with higher levels of CRP and IL-6.</div>
            </div>
        </div>

        <div class="takeaways-box">
            <p class="box-label">Key Takeaways</p>
            <ul>
                <li><strong>Inflammaging</strong> is an accelerated process in menopause where chronic, low-grade inflammation drives aging and disease.</li>
                <li>The loss of <strong>estrogen</strong> removes a significant anti-inflammatory shield, leading to a surge in IL-6 and TNF-alpha.</li>
                <li>Common symptoms like <strong>joint pain and hot flashes</strong> are often clinical manifestations of this underlying inflammatory state.</li>
                <li>Long-term risks of uncontrolled inflammaging include <strong>cardiovascular disease, Alzheimer's, and insulin resistance.</strong></li>
                <li>The <strong>T.H.R.I.V.E. Methodâ„¢</strong> prioritizes proactive "cooling" strategies to manage these risks before they become chronic conditions.</li>
            </ul>
        </div>

        <div class="references-box">
            <h4>References & Further Reading</h4>
            <ul>
                <li>Franceschi, C., et al. (2018). "Inflammaging: a new immuneâ€“metabolic viewpoint for age-related diseases." <i>Nature Reviews Endocrinology.</i></li>
                <li>Woods, N.F., et al. (2012). "C-reactive protein and the menopausal transition: The Study of Women's Health Across the Nation (SWAN)." <i>Menopause Journal.</i></li>
                <li>McCarthy, M., & Raval, A.P. (2020). "The peri-menopause in a woman's life: a systemic inflammatory phase that enables later neurodegenerative disease." <i>Journal of Neuroinflammation.</i></li>
                <li>Straub, R.H. (2007). "The complex role of estrogens in inflammation." <i>Endocrine Reviews.</i></li>
                <li>Monteleone, P., et al. (2021). "Inflammation and menopause: a novel target for intervention." <i>Climacteric.</i></li>
                <li>Gleicher, N., et al. (2022). "The 'Inflammaging' of the female reproductive system." <i>Frontiers in Endocrinology.</i></li>
            </ul>
        </div>

        <footer class="lesson-footer">
            <img src="/logoimg/LOGO_ACCREDI.png" alt="AccrediPro Academy" class="footer-logo">
            <p class="brand">AccrediPro Academy Â© 2024</p>
            <p class="copyright">Certified Menopause Support Coach Program | Module 4: Lesson 1</p>
        </footer>
    </div>
</body>

</html>